Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	47.05	61.64	9.74	15.56
Short-Term Investments	62.98	12.02	0.25	0.55
Cash & Short-Term Investments	110.03	73.66	9.99	16.11
Cash Growth	49.36%	637.44%	-37.98%	-
Other Current Assets	1.86	0.47	0.38	0.39
Total Current Assets	111.89	74.14	10.37	16.49
Net Property, Plant & Equipment	0.36	0.74	0.16	0.25
Other Long-Term Assets	4.94	2.64	0.01	0.01
Total Assets	117.18	77.51	10.54	16.76
Accounts Payable	2.07	2.3	1.04	0.26
Accrued Expenses	8.04	2.29	0.24	0.24
Current Portion of Leases	0.44	0.34	0.11	0.1
Total Current Liabilities	10.55	4.93	1.38	0.6
Long-Term Leases	-	0.44	0.05	0.16
Other Long-Term Liabilities	-	0.03	0	0.02
Total Long-Term Liabilities	-	0.47	0.05	0.18
Total Liabilities	10.55	5.39	1.43	0.78
Additional Paid-in Capital	222.47	3.68	2.94	2.61
Accumulated Other Comprehensive Income	0.08	-	-	-
Retained Earnings	-	-	-37.74	-30.53
Total Common Shareholders' Equity	222.55	3.68	-34.8	-27.92
Minority Interest	-	126.76	43.9	43.9
Shareholders' Equity	222.55	130.44	9.1	15.98
Total Liabilities & Equity	117.18	77.51	10.54	16.76
Total Debt	0.44	0.78	0.16	0.26
Net Cash (Debt)	109.59	72.88	9.83	15.84
Net Cash Growth	50.36%	641.67%	-37.97%	-
Net Cash Per Share	5.58	18.24	2.48	4.07
Book Value	222.55	3.68	-34.8	-27.92
Book Value Per Share	11.34	0.92	-8.79	-7.18
Tangible Book Value	222.55	3.68	-34.8	-27.92
Tangible Book Value Per Share	11.34	0.92	-8.79	-7.18

Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q